AGF Management Ltd. boosted its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 3.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 135,857 shares of the company's stock after purchasing an additional 4,819 shares during the quarter. AGF Management Ltd. owned about 0.16% of HealthEquity worth $13,035,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of HQY. Arcadia Investment Management Corp MI acquired a new position in shares of HealthEquity during the fourth quarter valued at $26,000. Smartleaf Asset Management LLC increased its stake in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares during the period. Proficio Capital Partners LLC bought a new stake in shares of HealthEquity during the 4th quarter worth about $39,000. UMB Bank n.a. raised its holdings in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after purchasing an additional 164 shares in the last quarter. Finally, Lindbrook Capital LLC raised its stake in shares of HealthEquity by 27.6% in the 4th quarter. Lindbrook Capital LLC now owns 750 shares of the company's stock worth $72,000 after buying an additional 162 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.
Shares of HealthEquity stock traded up $0.04 during midday trading on Wednesday, hitting $95.78. The company had a trading volume of 980,594 shares, compared to its average volume of 653,728. The stock has a market cap of $8.30 billion, a PE ratio of 87.87, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The business's 50 day simple moving average is $105.75 and its two-hundred day simple moving average is $94.93. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.
HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the company earned $0.40 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.
In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the business's stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.
Several equities research analysts have recently commented on HQY shares. Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 target price for the company. JMP Securities raised their target price on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a "neutral" rating and a $108.00 target price on the stock. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Finally, BTIG Research lifted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $113.54.
View Our Latest Research Report on HQY
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.